Impact of species-dependent differences on screening, design, and development of MAO B inhibitors
about
Key Targets for Multi-Target Ligands Designed to Combat NeurodegenerationMolecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidasesCharacterization of detergent purified recombinant rat liver monoamine oxidase B expressed in Pichia pastorisIn vitro Antioxidant and Enzymatic Approaches to Evaluate Neuroprotector Potential of Blechnum Extracts without Cytotoxicity to Human Stem CellsTopological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.MLP Tools: a PyMOL plugin for using the molecular lipophilicity potential in computer-aided drug design.Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies.Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B.Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B InhibitorFocusing on new monoamine oxidase inhibitors.Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential.Monoamine oxidase A and B substrates: probing the pathway for drug development.Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B.In Vivo Metabolic Trapping Radiotracers for Imaging Monoamine Oxidase-A and -B Enzymatic Activity.Monoamine Oxidase (MAO) Inhibitory Activity: 3-Phenylcoumarins versus 4-Hydroxy-3-phenylcoumarins
P2860
Q28077589-59BF5452-658C-4F84-917D-C235F0075BC5Q28475810-2D19D183-ED04-474D-9007-486E48ED436BQ28567792-95C37DF4-8133-45B1-AC31-23439A7E9BFAQ28829842-6738A267-BDD8-4222-9D18-471DB3375846Q34744450-CAF5C628-7B5C-4274-AE80-1B8221FFA1F1Q35159035-07CF42D2-5BE1-40E9-AFFD-6E58FABB5A66Q35942579-5B3B1C7C-2D3E-4030-BCD6-A94A6024F3EFQ36237385-A9BEB728-B82F-4B0D-A277-9812B53574C8Q36784782-C6E4D280-F1CE-4CB4-A565-ADD7AA96F38BQ37765566-EB819AD2-C59F-48D0-B3AA-A8048CDECE54Q38019012-7AF88A72-E76D-4C64-ADAA-5F6BF5425A97Q38217505-A61D3E0E-6F0F-46F1-9EAA-DD027BABD9B4Q40291145-9C7E395B-0FA9-49D0-A1B9-DDBAE989BAF7Q42016555-E56D3C41-73CC-4BF4-816E-470288D6767BQ42110236-5CB5AFF5-ED03-4477-8AA9-32FDDFBD884EQ57412731-6588A015-CDE4-401E-B7DA-231745E55850
P2860
Impact of species-dependent differences on screening, design, and development of MAO B inhibitors
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@ast
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@en
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@nl
type
label
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@ast
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@en
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@nl
prefLabel
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@ast
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@en
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@nl
P2093
P3181
P356
P1476
Impact of species-dependent di ...... evelopment of MAO B inhibitors
@en
P2093
Angelo Carotti
Antoine Daina
Elisabeth Favre
Francesco Leonetti
Juan Bravo
Laura Novaroli
Marco Catto
Marianne Reist
P304
P3181
P356
10.1021/JM060441E
P407
P577
2006-10-19T00:00:00Z